Kraig Biocraft Laboratories, Inc.
KBLB
$0.086
$0.00151.78%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 64.34% | -72.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 68.92% | -71.48% | |||
| Operating Income | -68.92% | 71.48% | |||
| Income Before Tax | -96.61% | 73.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -96.61% | 73.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -96.61% | 73.03% | |||
| EBIT | -68.92% | 71.48% | |||
| EBITDA | -70.20% | 71.81% | |||
| EPS Basic | -100.00% | 73.33% | |||
| Normalized Basic EPS | -66.67% | 70.00% | |||
| EPS Diluted | -100.00% | 73.33% | |||
| Normalized Diluted EPS | -66.67% | 70.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||